未登录

S

Stefanie Flunkert

Medical University of Graz

H指数:15

被引数:993

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

New infant formulas for healthy term infants: A randomized, controlled, double-blind, multicenter, non-inferiority design safety study

新型婴儿配方奶粉对健康足月婴儿的安全性研究：一项随机、对照、双盲、多中心、非劣效设计研究

IF2.6

2025-12-170

PRE

Longitudinal NF-L measurements in in vivo CSF samples for tracking pathology progression in mouse models of Gaucher and Niemann-Pick diseases

MOLECULAR GENETICS AND METABOLISM

IF3.5

2025-02-010

PRE

Application of preclinical gene therapy approaches

MOLECULAR GENETICS AND METABOLISM

IF3.5

2025-02-010

PRE

Compound muscle action potential as translational biomarker in a mouse model of Pompe disease

MOLECULAR GENETICS AND METABOLISM

IF3.5

2025-02-010

PRE

Motor deficits and brain pathology in the Parkinson's disease mouse model hA53Ttg

帕金森病小鼠模型hA53Ttg的运动障碍和脑病理学

FRONTIERS IN NEUROSCIENCE

IF3.2

2024-09-200

OAAI

Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice (vol 85, pg 1, 2024)

MOLECULAR METABOLISM

IF6.6

2024-08-010

OAAI

Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice

MOLECULAR METABOLISM

IF6.6

2024-07-010

OAAI

Histological characterization of the 6neo mouse model of Pompe disease

MOLECULAR GENETICS AND METABOLISM

IF3.5

2024-02-010

PRE

In vitro assessment of dietary bioactives for TFEB activation as a possible target to support cognitive and emotional wellbeing

JOURNAL OF FUNCTIONAL FOODS

IF4

2023-12-010

OAAI

Evaluating the effect of R-Baclofen and LP-211 on autistic behavior of the BTBR and Fmr1-KO mouse models

FRONTIERS IN NEUROSCIENCE

IF3.2

2023-03-304

OAAI

Editorial: Neuronopathic lysosomal storage diseases-specific neuronal characteristics and therapeutic approaches

FRONTIERS IN MOLECULAR NEUROSCIENCE

IF3.8

2022-11-080

OAAI

Behavioral characterization of homozygous 6neo mice as model of Pompe disease

MOLECULAR GENETICS AND METABOLISM

IF3.5

2022-02-010

PRE

Characterization of an APP/tau rat model of Alzheimer's disease by positron emission tomography and immunofluorescent labeling

通过正电子发射断层扫描和免疫荧光标记表征阿尔茨海默氏病的APP/tau大鼠模型

ALZHEIMERS RESEARCH & THERAPY

IF7.6

2021-10-168

OAAI

Evaluation of Neuropathological Features in the SOD1-G93A Low Copy Number Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

FRONTIERS IN MOLECULAR NEUROSCIENCE

IF3.8

2021-06-246

OAAI

Homozygosity of BACHD rats not only causes strong behavioral deficits in young female rats but also a reduced breeding success

IF2.6

2021-06-011

OAAI

Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer's Disease

JOURNAL OF ALZHEIMERS DISEASE

IF3.1

2021-02-256

OAAI

Quantification of Huntington's Disease Related Markers in the R6/2 Mouse Model

R6/2小鼠模型中亨廷顿氏病相关标志物的定量

FRONTIERS IN MOLECULAR NEUROSCIENCE

IF3.8

2021-01-1116

OAAI

Constant Levels of Tau Phosphorylation in the Brain of htau Mice

htau小鼠大脑中Tau磷酸化的恒定水平

FRONTIERS IN MOLECULAR NEUROSCIENCE

IF3.8

2020-08-286

OAAI

Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value

FRONTIERS IN NEUROSCIENCE

IF3.2

2020-06-1140

OAAI

Plasma pharmacokinetic and metabolism of [18F]THK-5317 are dependent on sex

NUCLEAR MEDICINE AND BIOLOGY

IF3

2020-05-014

OAAI